Galectin-3 Serum Levels Are Independently Associated With Microalbuminuria in Chronic Heart Failure Outpatients.

Journal: Research in cardiovascular medicine
Published Date: Dec 14, 2015

Abstract

BACKGROUND: Galectin-3 (Gal-3) is a novel biomarker reflecting inflammation status and fibrosis involving worsening of both cardiac and renal functions.

Authors

  • Massimo Iacoviello
    Department of Cardiothoracic, Cardiology Unit, Policlinic University Hospital, Bari, Italy.
  • Nadia Aspromonte
    DEA Department, Cardiology Unit, San Filippo Neri Hospital, Rome, Italy.
  • Marta Leone
    Department of Emergency and Organ Transplantation, School of Cardiology, University of Bari, Bari, Italy.
  • Valeria Paradies
    Department of Emergency and Organ Transplantation, School of Cardiology, University of Bari, Bari, Italy.
  • Valeria Antoncecchi
    Department of Emergency and Organ Transplantation, School of Cardiology, University of Bari, Bari, Italy.
  • Roberto Valle
    Cardiology Unit, Hospital Department, Chioggia ULSS 14, Chioggia, Italy.
  • Pasquale Caldarola
    Cardiology Unit, Cardiology Department, San Paolo Hospital, Bari, Italy.
  • Marco Matteo Ciccone
    Department of Emergency and Organ Transplantation, School of Cardiology, University of Bari, Bari, Italy.
  • Loreto Gesualdo
    Department of Diagnostic Pathology, Bioimages and Public Health, Policlinic University Hospital, Bari, Italy.
  • Francesca Di Serio
    Clinical Pathology Unit, University of Bari, Bari, Italy.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals